1.Determinants of worsening response to therapy in patients diagnosed with papillary thyroid carcinoma in a tertiary hospital.
Megan Margrethe D. BALINA ; Elaine C. CUNANAN ; Erick S. MENDOZA ; Bien J. MATAWARAN ; Sjoberg A. KHO
Journal of Medicine University of Santo Tomas 2025;9(1):1585-1596
INTRODUCTION
Papillary thyroid cancer (PTC) is generally considered to be an indolent disease with relatively good prognosis. However, some studies have shown that the Filipino population has a higher risk for disease recurrence compared to non-Filipino patients and hence early identification and management during the follow-up period would be beneficial, especially those in whom risk factors for recurrence were identified.
OBJECTIVEThis study aims to identify determinants for disease recurrence of patients with papillary thyroid carcinoma (as defined by the American Thyroid Association (ATA) guidelines 2015) diagnosed from January 1, 2013-December 31, 2017, seen at the University of Santo Tomas Hospital (USTH) outpatient endocrine clinic and underwent total thyroidectomy with or without radioactive iodine ablation therapy.
METHODOLOGYRetrospective review of outpatient medical records of 82 patients with PTC who underwent total thyroidectomy with or without radioactive iodine (RAI) therapy and achieved excellent response (ER) to therapy was performed. Baseline clinical profile such as age at diagnosis, sex, family history of thyroid cancer, family history of goiter, histopathology result, serial thyroglobulin (Tg), anti-thyroglobulin (anti-Tg) levels, whole body scan reports, neck ultrasound reports and RAI doses were collected. Logistic regression analysis was used to identify determinants to the development of worsening response.
RESULTSOf the 82 patients, 18 (21.9%) developed worsening response to therapy. Predictors of poor outcomes identified from previous studies such as age, sex, extent of disease, size and multifocality of tumors, ATA risk classification and initial dynamic risk assessment, RAI therapy, level of thyroid-stimulating hormone (TSH) suppression were analyzed. After logistic regression analysis, there was no significant association between variables and progression to worsening response that were previously identified in other studies.
CONCLUSIONEven though no significant association between investigated variables and worsening response were identified in this study, previous studies with larger populations that had exhibited positive association should be considered and hence current Philippine guidelines for the management of PTC must still be applied.
Human ; Thyroid Cancer ; Thyroid Neoplasms ; Thyroid Cancer, Papillary
2.The effect of telemedicine on self-care activities of patients with Type 2 Diabetes Mellitus and patient satisfaction during the Coronavirus-19 (COVID-19) pandemic: A repeated cross-sectional study
Dionise Ysabelle V. Bawal ; Elaine C. Cunanan ; Sjoberg A. Kho
Journal of Medicine University of Santo Tomas 2024;8(1):1354-1361
Introduction:
Patients with diabetes require regular follow-ups to achieve optimal glycemic targets. The coronavirus- 19 (COVID-19) pandemic resulted in interruptions in healthcare delivery placing greater importance on patient’s self-management of their condition. Telemedicine bridged the gap between the physician and patient that was created by community quarantines.
Objective:
To determine if there is a difference in patient’s self-care activities before and after using telemedicine using the Diabetes Self-Management Questionnaire (DSMQ).
Methodology:
A descriptive repeated cross-sectional study of patients with type 2 diabetes mellitus at the University of Santo Tomas Hospital who consulted via telemedicine using different available platforms were included. Self-care was measured using the DSMQ. Patient satisfaction with telemedicine was also assessed using a patient satisfaction survey.
Results:
An improvement in self-care practices was seen as significantly higher mean DSMQ scores after telemedicine consultations (6.79 ± 1.33 to 7.32 ± 1.21, p = 0.0015), with the highest scores on dietary control and physical activity. There was a statistically significant reduction in HbA1c on follow up (8.37 ± 2.31 to 7.31 ± 1.36; p<0.00001). Those with well-controlled diabetes (n = 14) at baseline remained to have good control while the proportion of those with poorly controlled diabetes (n = 34) showed improved glycemic control on follow up (p = 0.0045). Most patients were highly satisfied with telemedicine.
Conclusion
The use of telemedicine by patients with diabetes showed numerical improvement in both self-care practices and glycemic control. These findings imply that telemedicine may be mainstreamed as part of diabetes care among Filipinos.
COVID-19
;
Telemedicine
3.Physicians’ knowledge, attitudes and practices on the diagnosis and management of osteoporosis in a tertiary hospital in Manila
Dylan Jansen V. Taytayon ; Elaine C. Cunanan ; Erick S. Mendoza ; Julie T. Li-Yu ; Eric Ranniel P. Guevara ; Jo Rocel Z. Lacson
Journal of Medicine University of Santo Tomas 2024;8(2):1459-1481
Osteoporosis is a major public health concern leading to significant morbidity and mortality, especially in the elderly population. However, this disease is underdiagnosed and, as a result, undertreated. This cross-sectional study aims to determine the knowledge, attitudes and practices (KAP) of physicians in the diagnosis and management of osteoporosis, which would help identify key areas of improvement in the care of patients with this disease. One hundred and nine physicians answered an online questionnaire looking at their KAP on the diagnosis and management of osteoporosis, and their answers were analyzed using descriptive statistics, Pearson’s correlation and the Chi-square test. More than half of the participants obtained satisfactory scores on knowledge, and majority had neutral to positive attitude regarding osteoporosis. A statistically significant correlation was seen between having low knowledge and negative attitudes on osteoporosis screening and management.
4.The difference in risk factors between adults With early-onset (<40 Years Old) versus late-onset (≥40 Years Old) type 2 Diabetes in a University Hospital From January 2015-December 2017
Marilyn Katrina C. CARO ; Elaine C. CUNANAN
Journal of Medicine University of Santo Tomas 2022;6(2):1009-1017
Background:
Diabetes will remain a threat to global health. No longer just a disorder of mature age, there is now a well-recognized trend towards the young. Early diagnosis leads to early intervention and prevention of complications in this susceptible but vital portion of the population.
Objective:
To compare the risk factors predisposing adults to early-onset (<40 years old) versus late-onset (≥40 years old) type 2 diabetes at the University of Santo Tomas Hospital from January 2015-December 2017.
Methods:
This is a retrospective review of medical records. All adult patients who fulfilled the inclusion criteria from January 2015 to December 2017 were included in the study. Data from charts were reviewed and analyzed.
Results:
The early-onset group had a mean age of 34 years, while the late-onset group had a mean age of 51 years. The early-onset diabetics were mostly obese, had higher HbA1c, worse lipid profiles, and had a positive family history of diabetes. Only a BMI of >27.50 kg/m2 was found to be a significant risk factor contributing to early-onset of diabetes. Myocardial infarction and nephropathy were more frequent in the late-onset group while retinopathy was more common in the early-onset group. Lastly, only retinopathy and neuropathy were significantly associated with longer duration of diabetes.
Conclusion
The mean age of Filipinos was at least 5 years younger than the studies done on Caucasians. Most patients in the early-onset group were obese and had worse metabolic profiles. Retinopathy was more common in the early-onset group, while myocardial infarction and neuropathy were more common in the latter.
Risk Factors|philippines|early Diagnosis
5.The association of antenatal steroids and hypoglycemia in preterm neonates.
John Ryan G. VIAR ; Elaine C. CUNANAN
Journal of Medicine University of Santo Tomas 2021;5(1):604-610
Objective: Antenatal steroids have shown to decrease the rate of neonatal complications and morbidity; however, neonates are predisposed to significant hypoglycemia resulting in invasive interventions and prolonged nursery admissions. The risk of hypoglycemia in the preterm has been well studied, but the association of antenatal steroids and hypoglycemia in preterm neonates has not been well explored. Thus, we sought to determine the association of antenatal steroids given to mothers who delivered prematurely and the development of neonatal hypoglycemia.
Methods: A cross-sectional study using chart review was done on mother-preterm neonate pairs admitted in the charity obstetrical ward of The University of Santo Tomas Hospital from January 1, 2018 to December 31, 2019. The subjects were mothers either given or not given antenatal steroids before preterm delivery and their respective neonates. The provision of antenatal steroids was the primary exposure, while neonatal hypoglycemia was the primary outcome. Measurement of association was done using odds ratios. Univariate and multivariate logistic regression analyses were done.
Results: Of the 69 preterm neonates included in the study, hypoglycemia was observed in 14 neonates, among which 8 neonates were exposed to antenatal steroids. After examining the association using Fisher's exact formula and controlling for potential confounders, neonatal hypoglycemia was not significantly higher among neonates exposed to antenatal steroids.
Conclusion: Antenatal steroids given to mothers who delivered preterm were not associated with the development of neonatal hypoglycemia. A prospective study model, larger population size and longer study coverage should be made to strengthen the outcome of the study.
6.Prevalence and Clinical Outcomes of Patients with Diabetic Ketoacidosis/Hyperglycemic Hyperosmolar Syndrome and COVID-19: A Systematic Review
Shane B. Villamonte ; Marilyn Katrina C. Caro ; Elaine C. Cunanan
Philippine Journal of Internal Medicine 2020;59(2):101-106
BACKGROUND AND OBJECTIVES. Several reports have shown that coexistence of diabetes mellitus and COVID-19 is one of the risk factors for poor outcome and increased mortality. Rapid metabolic deterioration with development of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar syndrome (HHS) may result due to the acute insulin secretory capacity loss, stress condition and the cytokine storm. In this review, we aim to describe the prevalence of hyperglycemic crises(DKA/HHS) in patients with COVID-19 infection as well as their clinical outcomes.
METHODS. An intensive search was done using the WebMD, PubMed, Medline and Google Scholar databases for articles published between December 2019 to October 2020 that identified the number of patients who developed DKA and/or HHS among those who were admitted for COVID-19. Their clinical outcomes were likewise described.
RESULTS. This review included 4 articles in which individual quality was assessed. A total of 1282 patients were admitted for COVID-19 and the prevalence of DKA was 1.32%. HHS was not reported in any of the studies. Five (29.4%) of the patients with DKA and COVID-19 died and 12 (70.6%) recovered.
CONCLUSIONS. A significant number of COVID-19 patients developed DKA and it is associated with a high mortality rate. This reimposes the need for an appropriate algorithm for the optimal management of concomitant COVID 19 and hyperglycemic crises to avoid morbidity and mortality. Additionally, there is paucity of large-scale studies describing the prevalence of DKA/HHS in patients with COVID-19.
Diabetic Ketoacidosis
;
COVID-19
;
Water-Electrolyte Imbalance
;
Acid-Base Imbalance
;
Coma
7.Prevalence of hypoglycemia among type 2 diabetics undergoing hemodialysis in a university hospital
Maria Concepcion H GUNGON ; Elaine C CUNANAN
Journal of Medicine University of Santo Tomas 2020;4(2):510-517
Background:
The overall increase in the number of
people with diabetes mellitus has a major impact on
the increasing number of patients with diabetic kidney
disease (DKD). Hypoglycemia that is brought about
by altered glucose homeostasis and the hemodialysis
process in patients with DKD poses a great challenge
to clinicians in achieving blood glucose control. This
study has been undertaken to evaluate the prevalence
of hypoglycemia among diabetics undergoing hemodialysis and determine the clinical factors predicting
the development of hypoglycemia.
Methods:
We conducted a prospective, cross-sectional study that included 75 patients with diabetes
mellitus undergoing maintenance hemodialysis at the
University of Santo Tomas Hospital, Center for Kidney
Disease. The patients’ predialysis and hourly intradialytic serum glucose levels were measured until the
end of the session. Hypoglycemia was considered as
a blood glucose ≤70 mg/dL with/without symptoms.
Results:
Elderly patients and in-hospital patients
tend to develop hypoglycemia with a p-value of
0.0028 and 0.001, respectively. Old age (p-value
0.0093), female sex (p-value 0.0224), hypertension
(p-value 0.0301), CAD (p-value 0.0058), frequency of hemodialysis (p-value 0.0000), no caloric intake
during the dialysis session (p-value 0.0022) and admission (p-value 0.0007) predicted hypoglycemia in
our study
Conclusions
In conclusion, the prevalence of hypoglycemia among patients with type 2 diabetes mellitus
undergoing maintenance hemodialysis in our setting
is 12%. There is an increased rate of hypoglycemia
amongst the elderly as well as admitted patients. Our
results identifi ed old age, presence of CAD, increased
frequency of hemodialysis and hospital admission as
the predictors of hypoglycemia.
Renal Dialysis
;
Hypoglycemia
;
Kidney Failure, Chronic
8.A retrospective cohort study in a university hospital evaluating the effect of maternal glucose containing intravenous fluid in neonatal glycemia
Gelinemae G MALAZA ; Elaine C CUNANAN
Journal of Medicine University of Santo Tomas 2019;3(1):290-294
Abstract Maternal hyperglycemia during the peripartum period is highly correlated with fetal hyperinsulinemia and consequent neonatal hypoglycemia.
Liberal use of intravenous glucose therapy prior to
delivery can potentially cause maternal hyperglycemia, therefore, it is prudent to implement all preventive measures.
This study aims to determine the occurrence of neonatal hypoglycemia with intravenous glucose therapy prior to delivery in maternal diabetes mellitus.
This was a retrospective cohort study of neonates
born from diabetic mothers at the University of Santo
Tomas Hospital Clinical and Private Divisions from
January 1, 2013 to December 15, 2017. Clinical
information gathered was divided into maternal and
neonatal characteristics. Maternal intravenous fl uid
use, rate, and duration were noted; maternal and
neonatal blood glucose results were obtained.
There were 109 infants of diabetic mothers, of
which 105 were delivered as singleton and 4 from twin pregnancies. Neonatal hypoglycemia was
present in 14.68%. Comparing the risk factors, there
was a higher amount of glucose infused to the mothers whose offspring developed hypoglycemia compared to those without hypoglycemia. Statistically,
this did not demonstrate a signifi cant difference. The
rate of glucose infusion and frequency of maternal
insulin use were similar between the groups. Linear
correlation was not evident when the total glucose
infused and the rate of intravenous glucose infusion
was compared to the neonatal glucose in the fi rst
hour of life.
Based on this study, routine administration of glucose-containing intravenous fl uid did not infl uence
the incidence of neonatal hypoglycemia. It is recommended that further prospective studies be conducted.
Diabetes, Gestational
;
9.Diagnosis of gestational diabetes mellitus using the international association of the diabetes and pregnancy study groups criteria and adverse pregnancy outcomes among a cohort of Filipino women: An association analysis
Kristine S. de Luna ; Elaine C. Cunanan
Philippine Journal of Internal Medicine 2017;55(4):1-8
Introduction:
Locally, there is no unified set of diagnostic
criteria for gestational diabetes mellitus (GDM) and this can
lead to potential confusion on the part of the physician and
the patient as well. Moreover, whether the adoption of the
International Association of the Diabetes and Pregnancy
Study Groups (IADPSG) threshold values for GDM diagnosis
among Filipino women is appropriate is still unclear. This study
serves to give a clinically important insight whether utilizing
the abovementioned diagnostic criteria is appropriate in
the local setting or not. The study aims to determine the
association of the threshold values set up by the IADPSG to
diagnose GDM with adverse pregnancy outcomes among
a cohort of Filipino women.
Methods:
A retrospective analysis of medical files of the
women diagnosed with GDM using the IADPSG criteria from
January 2013 to March 2016 was done. The results of seventyfive gram oral glucose tolerance test (75-g OGTT) were
recorded. The association between each IADPSG threshold
values (fasting blood glucose of ≥92 mg/dL, one-hour post
glucose load of ≥180 mg/dL, two-hour post glucose load
of ≥153 mg/dL) used to define GDM and maternal and
perinatal outcomes were determined.
Results:
One hundred twenty women with GDM were
included in the analysis. Each of IADPSG-defined cut-off values was not significantly associated with increased
likelihood of having adverse maternal outcomes namely:
hypertensive disorders of pregnancy, miscarriage, primary
cesarean section, operative vaginal delivery, and maternal
death. Similarly, the likelihood of perinatal outcomes namely:
macrosomia, perinatal death, prematurity, birth injuries,
congenital anomalies, neonatal hypoglycemia, jaundice,
low APGAR score, acute respiratory distress syndrome, and
infection were not significantly higher even if these cut-off
values were met. Of note, high odds ratio was noted for neonatal
hypoglycemia at FBS >92 mg/dL and <92 mg/dL and the low
Apgar Score in first minute at >153 mg/dL and <153 mg/dL
even though they were statistically not significant.
Conclusion
We did not find a statistically significant positive
association between IADPSG threshold values and specified
adverse maternal and perinatal outcomes.
Diabetes, Gestational
10.Prevalence of Hyponatremia in Hypothyroid Patients during Radioactive ¹³¹I Ablation for Differentiated Thyroid Cancer: Single Institution Experience.
Juan Carlo P DAYRIT ; Elaine C CUNANAN ; Sjoberg A KHO
Endocrinology and Metabolism 2016;31(3):410-415
BACKGROUND: Hyponatremia developing in hypothyroid patients has been encountered in clinical practice; however, its prevalence has not been well established. METHODS: Thirty patients diagnosed with differentiated thyroid cancer, rendered hypothyroid after surgery and levothyroxine withdrawal, and who are for radioactive iodine (RAI) ablation were included. Serum sodium concentrations were measured twice, at the time of admission for RAI ablation, and before discharge after increased oral fluid intake. The outcome measures were to determine the prevalence of hyponatremia among hypothyroid patients prior to RAI ablation and after oral hydration post-RAI, and to correlate the serum sodium levels pre-RAI and post-RAI with thyroid-stimulating hormone (TSH) concentration and age. RESULTS: Thirty patients were included, with ages from 23 to 65 years old (median, 40). Two patients (6.7%) were hyponatremic prior to RAI ablation, and eight patients (26.7%) had mild hyponatremia (130 to 134 mEq/L) after RAI and hydration. There was no significant correlation between TSH levels and serum sodium levels prior to or after RAI. There was also no significant correlation between pre- and post-RAI sodium concentration and age. CONCLUSIONS: The prevalence of hyponatremia pre-RAI was 6.7%, and 26.7% post-RAI. No significant correlation was noted between TSH concentration and age on pre- or post-RAI sodium concentrations. Routine measurement of serum sodium post-RAI/isolation is still not advised. Measurement of sodium post-RAI may be considered in patients who are elderly, with comorbid conditions or on medications.
Aged
;
Humans
;
Hyponatremia*
;
Hypothyroidism
;
Iodine
;
Outcome Assessment (Health Care)
;
Prevalence*
;
Sodium
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyrotropin
;
Thyroxine


Result Analysis
Print
Save
E-mail